The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
GluN2D-Containing N-methyl-d-Aspartate Receptors Mediate Synaptic Transmission in Hippocampal Interneurons and Regulate Interneuron Activity
Open accessAbstract
N-methyl-d-aspartate receptors (NMDARs) are ionotropic glutamatergic receptors that have been implicated in learning, development, and neuropathological conditions. They are typically composed of GluN1 and GluN2A-D subunits. Whereas a great deal is known about the role of GluN2A- and GluN2B-containing NMDARs, much less is known about GluN2D-containing NMDARs. Here we explore the subunit composition of synaptic NMDARs on hippocampal interneurons. GluN2D mRNA was detected by single-cell PCR and in situ hybridization in diverse interneuron subtypes in the CA1 region of the hippocampus. The GluN2D subunit was detectable by immunoblotting and immunohistochemistry in all subfields of the hippocampus in young and adult mice. In whole-cell patch-clamp recordings from acute hippocampal slices, (+)-CIQ, the active enantiomer of the positive allosteric modulator CIQ, significantly enhanced the amplitude of the NMDAR component of miniature excitatory postsynaptic currents (mEPSCs) in CA1 interneurons but not in pyramidal cells. (+)-CIQ had no effect in slices from Grin2d-/- mice, suggesting that GluN2D-containing NMDARs participate in excitatory synaptic transmission onto hippocampal interneurons. The time course of the NMDAR component of the mEPSC was unaffected by (+)-CIQ potentiation and was not accelerated in slices from Grin2d-/- mice compared with wild-type, suggesting that GluN2D does not detectably slow the NMDAR EPSC time course at this age. (+)-CIQ increased the activity of CA1 interneurons as detected by the rate and net charge transfer of spontaneous inhibitory postsynaptic currents (sIPSCs) recorded from CA1 pyramidal cells. These data provide evidence that interneurons contain synaptic NMDARs possessing a GluN2D subunit, which can influence interneuron function and signal processing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, Grin2d has been found in hippocampal interneurons and enhances their activity due to its involvement in synaptic transmission66.”
From Elimination of the four extracellular matrix molecules tenascin-C, tenascin-R, brevican and neurocan alters the ratio of excitatory and inhibitory synapses (2019) · cites this paper as [66]
In the citing paper
“In addition, ketamine is reported to have higher affinity for GluN2D NMDAR subunits 40, 41, which are highly expressed in forebrain inhibitory interneurons 42, 43.”
From Mechanisms of ketamine action as an antidepressant (2018) · cites this paper as [43]
Citations
Cites
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568
Self-citationMonyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535
Choi, D. W. (1992) · Journal of Neurobiology · doi:10.1002/neu.480230915 · Cited by 2,329
Functional Repression of cAMP Response Element in 6-Hydroxydopamine-treated Neuronal Cells
Chalovich, E. M., Zhu, J.-H., Caltagarone, J., Bowser, R., & Chu, C. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602632200 · Cited by 1,385
Automated design of ligands to polypharmacological profiles
Besnard, J., Ruda, G. F., Setola, V., Abecassis, K., Rodriguiz, R. M., Huang, X.-P., Norval, S., Sassano, M. F., Shin, A. I., Webster, L. A., et al. (2012) · Nature · doi:10.1038/nature11691 · Cited by 832
Molecular and Physiological Diversity of Cortical Nonpyramidal Cells
Cauli, B., Audinat, E., Lambolez, B., Angulo, M. C., Ropert, N., Tsuzuki, K., Hestrin, S., & Rossier, J. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-10-03894.1997 · Cited by 738
Functional and Pharmacological Differences Between Recombinant N -Methyl- d -Aspartate Receptors
Vicini, S., Wang, J. F., Li, J. H., Zhu, W. J., Wang, Y. H., Luo, J. H., Wolfe, B. B., & Grayson, D. R. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.79.2.555 · Cited by 674
Channel kinetics determine the time course of NMDA receptor-mediated synaptic currents
Lester, R. A. J., Clements, J. D., Westbrook, G. L., & Jahr, C. E. (1990) · Nature · doi:10.1038/346565a0 · Cited by 564
AMPA receptor subunits expressed by single purkinje cells
Lambolez, B., Audinat, É., Bochet, P., Crépel, F., & Rossier, J. (1992) · Neuron · doi:10.1016/0896-6273(92)90164-9 · Cited by 553
Preskorn, S., Baker, B., Kolluri, S., Menniti, F. S., Krams, M., & Landen, J. W. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31818a6cea · Cited by 524
Cited by
Sorted by citations
Mechanisms of ketamine action as an antidepressant
Zanos, P., & Gould, T. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.255 · Cited by 1,127
Hippocampal GABAergic Inhibitory Interneurons
Pelkey, K. A., Chittajallu, R., Craig, M. T., Tricoire, L., Wester, J. C., & McBain, C. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00007.2017 · Cited by 889
Self-citationStructure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Hansen, K. B., Wollmuth, L. P., Bowie, D., Furukawa, H., Menniti, F. S., Sobolevsky, A. I., Swanson, G. T., Swanger, S. A., Greger, I. H., Nakagawa, T., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000131 · Cited by 686
Self-citationThe Role of NMDA Receptors in Alzheimer’s Disease
Liu, J., Chang, L., Song, Y., Li, H., & Wu, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00043 · Cited by 535
Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies
Oyrer, J., Maljevic, S., Scheffer, I. E., Berkovic, S. F., Petrou, S., & Reid, C. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014456 · Cited by 315
NMDA Receptors in the Central Nervous System
Hansen, K. B., Yi, F., Perszyk, R. E., Menniti, F. S., & Traynelis, S. F. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7321-7_1 · Cited by 216
Self-citationThe stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders
Sanacora, G., Yan, Z., & Popoli, M. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00540-x · Cited by 197
Swanger, S. A., Chen, W., Wells, G., Burger, P. B., Tankovic, A., Bhattacharya, S., Strong, K. L., Hu, C., Kusumoto, H., Zhang, J., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.10.002 · Cited by 183
Self-citationDistinct roles of GRIN2A and GRIN2B variants in neurological conditions
Myers, S. J., Yuan, H., Kang, J., Tan, F. C. K., Traynelis, S. F., & Low, C. (2019) · F1000Research · doi:10.12688/f1000research.18949.1 · Cited by 151
Self-citationRegulation of NMDA glutamate receptor functions by the GluN2 subunits
Vieira, M., Yong, X. L. H., Roche, K. W., & Anggono, V. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14970 · Cited by 151
Triheteromeric NMDA receptors: from structure to synaptic physiology
Stroebel, D., Casado, M., & Paoletti, P. (2017) · Current Opinion in Physiology · doi:10.1016/j.cophys.2017.12.004 · Cited by 154
Extending the small-molecule similarity principle to all levels of biology with the Chemical Checker
Duran-Frigola, M., Pauls, E., Guitart-Pla, O., Bertoni, M., Alcalde, V., Amat, D., Juan-Blanco, T., & Aloy, P. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0502-7 · Cited by 126
Gottschling, C., Wegrzyn, D., Denecke, B., & Faissner, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-50404-9 · Cited by 111
Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry
Hanson, J. E., Yuan, H., Perszyk, R. E., Banke, T. G., Xing, H., Tsai, M., Menniti, F. S., & Traynelis, S. F. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01614-3 · Cited by 121
Self-citationHealth benefits of methylxanthines in neurodegenerative diseases
Oñatibia‐Astibia, A., Franco, R., & Martínez‐Pinilla, E. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600670 · Cited by 110
Hanson, J. E., Ma, K., Elstrott, J., Weber, M., Saillet, S., Khan, A. S., Simms, J. A., Liu, B., Kim, T. A., Yu, G.-Q., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.030 · Cited by 91
Hanson, E., Armbruster, M., Lau, L. A., Sommer, M., Klaft, Z., Swanger, S. A., Traynelis, S. F., Moss, S. J., Noubary, F., Chadchankar, J., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1392-18.2019 · Cited by 89
Self-citationFunctional and pharmacological properties of triheteromeric GluN1/2B/2D NMDA receptors
Yi, F., Bhattacharya, S., Thompson, C. M., Traynelis, S. F., & Hansen, K. B. (2019) · The Journal of Physiology · doi:10.1113/jp278168 · Cited by 74
Self-citationGeoffroy, C., Paoletti, P., & Mony, L. (2021) · The Journal of Physiology · doi:10.1113/jp280875 · Cited by 73
Ravikrishnan, A., Gandhi, P. J., Shelkar, G. P., Liu, J., Pavuluri, R., & Dravid, S. M. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.03.011 · Cited by 73
Swanger, S. A., Vance, K. M., Acker, T. M., Zimmerman, S. S., DiRaddo, J. O., Myers, S. J., Bundgaard, C., Mosley, C. A., Summer, S. L., Menaldino, D. S., et al. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00329 · Cited by 60
Self-citationYu, Y., Lin, Y., Takasaki, Y., Wang, C., Kimura, H., Xing, J., Ishizuka, K., Toyama, M., Kushima, I., Mori, D., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0061-y · Cited by 57
Lv, S., Yao, K., Zhang, Y., & Zhu, S. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109378 · Cited by 60
Camp, C. R., & Yuan, H. (2019) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2019.12.007 · Cited by 54
Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant
Xu, S., Yao, X., Li, B., Cui, R., Zhu, C., Wang, Y., & Yang, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.740996 · Cited by 53
Alsaad, H. A., DeKorver, N. W., Mao, Z., Dravid, S. M., Arikkath, J., & Monaghan, D. T. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2526-7 · Cited by 52
Biased modulators of NMDA receptors control channel opening and ion selectivity
Perszyk, R. E., Swanger, S. A., Shelley, C., Khatri, A., Fernández‐Cuervo, G., Epplin, M. P., Zhang, J., Le, P., Bülow, P., Garnier‐Amblard, E. C., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-019-0449-5 · Cited by 45
Self-citationTemporal Dynamics and Neuronal Specificity of Grin3a Expression in the Mouse Forebrain
Murillo, A., Navarro, A. I., Puelles, E., Zhang, Y., Petros, T. J., & Pérez‐Otaño, I. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa330 · Cited by 42
Yao, L., Grand, T., Hanson, J. E., Paoletti, P., & Zhou, Q. (2018) · Nature Communications · doi:10.1038/s41467-018-06512-7 · Cited by 46
Gawande, D. Y., Narasimhan, K. K. S., Shelkar, G. P., Pavuluri, R., Stessman, H. A. F., & Dravid, S. M. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.03.020 · Cited by 41
Properties of Triheteromeric N-Methyl-d-Aspartate Receptors Containing Two Distinct GluN1 Isoforms
Yi, F., Zachariassen, L. G., Dorsett, K. N., & Hansen, K. B. (2018) · Molecular Pharmacology · doi:10.1124/mol.117.111427 · Cited by 39
Camp, C. R., Vlachos, A., Klöckner, C., Krey, I., Banke, T. G., Shariatzadeh, N., Ruggiero, S. M., Galer, P. D., Park, K., Caccavano, A., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05298-9 · Cited by 41
Self-citationAdam, E. M., Kowalski, M., Akeju, O., Miller, E. K., Brown, E. N., McCarthy, M. M., & Kopell, N. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2402732121 · Cited by 37
NMDA Receptors in Neurodevelopmental Disorders: Pathophysiology and Disease Models
Tumdam, R., Hussein, Y., Garin-Shkolnik, T., & Stern, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212366 · Cited by 45
A Role for Prefrontal Cortical NMDA Receptors in Murine Alcohol-Heightened Aggression
Newman, E. L., Terunuma, M., Wang, T. L., Hewage, N., Bicakci, M. B., Moss, S. J., DeBold, J. F., & Miczek, K. A. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.253 · Cited by 38
Ketamine for post-traumatic stress disorders and it's possible therapeutic mechanism
Asim, M., Wang, B., Hao, B., & Wang, X. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105044 · Cited by 37
Scotton, E., Antqueviezc, B., Vasconcelos, M., Dalpiaz, G., Géa, L. P., Goularte, J. F., Colombo, R., & Rosa, A. R. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114963 · Cited by 37
NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology
Mellone, M., Zianni, E., Stanic, J., Campanelli, F., Marino, G., Ghiglieri, V., Longhi, A., Thiolat, M.-L., Li, Q., Calabresi, P., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.09.021 · Cited by 37
NMDA receptor function in inhibitory neurons
Booker, S. A., & Wyllie, D. J. A. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108609 · Cited by 36
Garst-Orozco, J., Malik, R., Lanz, T. A., Weber, M. L., Xi, H. S., Arion, D., Enwright, J. F., Lewis, D. A., O’Donnell, P., Sohal, V. S., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233895 · Cited by 32
Bygrave, A. M., Kilonzo, K., Kullmann, D. M., Bannerman, D. M., & Kätzel, D. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00835 · Cited by 35
Kinetic models for activation and modulation of NMDA receptor subtypes
Iacobucci, G. J., & Popescu, G. (2018) · Current Opinion in Physiology · doi:10.1016/j.cophys.2018.02.002 · Cited by 30
Contribution of NMDA Receptors to Synaptic Function in Rat Hippocampal Interneurons
Booker, S. A., Sumera, A., Kind, P. C., & Wyllie, D. J. A. (2021) · eNeuro · doi:10.1523/eneuro.0552-20.2021 · Cited by 32
Epplin, M. P., Mohan, A., Harris, L. D., Zhu, Z., Strong, K. L., Bacsa, J., Le, P., Menaldino, D. S., Traynelis, S. F., & Liotta, D. C. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01733 · Cited by 27
Self-citationAutoimmunity and NMDA receptor in brain disorders: Where do we stand?
Hunter, D., Jamet, Z., & Groc, L. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105161 · Cited by 28
PTC-174, a positive allosteric modulator of NMDA receptors containing GluN2C or GluN2D subunits
Yi, F., Rouzbeh, N., Hansen, K. B., Xu, Y., Fanger, C. M., Gordon, E., Paschetto, K. A., Menniti, F. S., & Volkmann, R. A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107971 · Cited by 25
Elmasri, M., Lotti, J. S., Aziz, W., Steele, O. G., Karachaliou, E., Sakimura, K., Hansen, K. B., & Penn, A. C. (2022) · Brain Sciences · doi:10.3390/brainsci12060789 · Cited by 22
Structural basis for channel gating and blockade in tri-heteromeric GluN1-2B-2D NMDA receptor
Kang, H., Epstein, M., Banke, T. G., Perszyk, R. E., Simorowski, N., Paladugu, S., Liotta, D. C., Traynelis, S. F., & Furukawa, H. (2025) · Neuron · doi:10.1016/j.neuron.2025.01.013 · Cited by 21
Self-citationTargeting prefrontal cortex GABAergic microcircuits for the treatment of alcohol use disorder
Fish, K. N., & Joffe, M. E. (2022) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2022.936911 · Cited by 20
Strong, K. L., Epplin, M. P., Bacsa, J., Butch, C. J., Burger, P. B., Menaldino, D. S., Traynelis, S. F., & Liotta, D. C. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00239 · Cited by 21
Self-citationGao, M., Hu, F., Zeng, X.-D., Tang, H.-L., Zhang, H., Jiang, W., Yan, H.-J., Shi, H., Shu, Y., & Long, Y. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.103633 · Cited by 18
Morris, P. G., Mishina, M., & Jones, S. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00354 · Cited by 18
Eapen, A. V., Fernández‐Fernández, D., Georgiou, J., Bortolotto, Z. A., Lightman, S. L., Jane, D. E., Volianskis, A., & Collingridge, G. L. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108833 · Cited by 19
NMDAR PAMs: Multiple Chemotypes for Multiple Binding Sites
Goldsmith, P. J. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191011095341 · Cited by 16
Strong, K. L., Epplin, M. P., Ogden, K. K., Burger, P. B., Kaiser, T. M., Wilding, T. J., Kusumoto, H., Camp, C. R., Shaulsky, G. H., Bhattacharya, S., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00561 · Cited by 16
Self-citationFlynn, L. T., & Gao, W. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02235-4 · Cited by 16
Polli, F. S., & Kohlmeier, K. A. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107744 · Cited by 15
Mao, Z., He, S., Mesnard, C., Synowicki, P., Zhang, Y., Chung, L., Wiesman, A. I., Wilson, T. W., & Monaghan, D. T. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146571 · Cited by 14
Widman, A. J., & McMahon, L. L. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.05.001 · Cited by 13
Yang, M., Wu, X., Ding, C., Zhang, G., Li, M., Lv, L., Li, Y., Sun, D.-W., & Jian-jun, Z. (2021) · Neuroreport · doi:10.1097/wnr.0000000000001695 · Cited by 14
The NMDA receptor subunit GluN2D is a potential target for rapid antidepressant action
Vestring, S., Veleanu, M., Perez, M. C., Schuberth, L. E., Bronnec, M., Li, A., Würz, L. M., Erdogdu, F., Stocker, J., Moos, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66774-w · Cited by 13
Xiao, Y., Luo, H., Yang, W. Z., Zeng, Y., Shen, Y., Ni, X., Shi, Z., Zhong, J., Liang, Z., Fu, X., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00048 · Cited by 12
Xie, L., McDaniel, M. J., Perszyk, R. E., Kim, S., Cappuccio, G., Shapiro, K. A., Cabello, B. M., Sanchez-Lara, P. A., Grand, K., Zhang, J., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04705-y · Cited by 10
Self-citationUllman, E. Z., Perszyk, R. E., Paladugu, S., Fritzemeier, R. G., Akins, N. S., Jacobs, L., Liotta, D. C., & Traynelis, S. F. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.124.001019 · Cited by 10
Self-citationTartaglione, A. M., Serafini, M. M., Ferraris, F., Raggi, A., Mirabello, A., Benedetto, R. D., Ricceri, L., Midali, M., Cubadda, F., Minghetti, L., et al. (2022) · Nutrients · doi:10.3390/nu14163269 · Cited by 10
Potential Roles for the GluN2D NMDA Receptor Subunit in Schizophrenia
Vinnakota, C., Hudson, M. R., Jones, N. C., Sundram, S., & Hill, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411835 · Cited by 7
Ashourpour, F., Jafari, A., & Babaei, P. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1837800 · Cited by 10
Köhler, I., Rennau, L.-M., Hoffmann, L., Demianchuk, E., Kaczmarski, M., Sobierajski, E., Riedel, C., & Wahle, P. (2025) · Cerebral Cortex · doi:10.1093/cercor/bhaf136 · Cited by 8
Freyssin, A., Carles, A., Guehairia, S., Rubinstenn, G., & Maurice, T. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109733 · Cited by 8
Callahan, P. M., Terry, A. V., Nelson, F. R., Volkmann, R. A., Vinod, A., Zainuddin, M., & Menniti, F. S. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107994 · Cited by 8
Synaptic dysregulation in a mouse model of GRIN2D developmental and epileptic encephalopathy
Teoh, J. J., Simko, J., Camp, C. R., Liu, C. J., Wang, W., Williams, D. J., Ma, L., Soundararajan, D., Martin, C., Taylor, N. D., et al. (2025) · Brain · doi:10.1093/brain/awaf125 · Cited by 8
Self-citationPromises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression
Bartsch, C. J., & Nordman, J. C. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.938044 · Cited by 7
Vinnakota, C., Schroeder, A., Du, X., Ikeda, K., Ide, S., Mishina, M., Hudson, M. R., Jones, N. C., Sundram, S., & Hill, R. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25257 · Cited by 5
Inhibition of GluN2B-containing N -methyl- D- aspartate receptors by radiprodil
Banke, T. G., Regan, M. C., Perszyk, R. E., Zhang, L., Xing, H., Chen, J., Won, S., Simorowski, N., Diaz, E. S., Kim, S., et al. (2025) · Brain · doi:10.1093/brain/awaf355 · Cited by 6
Self-citationWang, Y., Xu, J., Zhou, X., Che, L., Qiu, M., Liu, Y., Gao, M., & Yang, Z. (2025) · Advanced Science · doi:10.1002/advs.202516024 · Cited by 9
Camp, C. R., Banke, T. G., Xing, H., Yu, K., Perszyk, R. E., Epplin, M. P., Akins, N. S., Zhang, J., Benke, T. A., Yuan, H., et al. (2025) · The Journal of Physiology · doi:10.1113/jp288343 · Cited by 8
Self-citationZhu, M., Perkins, M. G., Lennertz, R. C., Abdulzahir, A., & Pearce, R. A. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109215 · Cited by 5
Rademacher, J., Grent-‘t-Jong, T., Rivolta, D., Sauer, A., Scheller, B., González‐Burgos, G., Metzner, C., & Uhlhaas, P. J. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013118 · Cited by 6
GluN2D expression is regulated by restraint stress and supports active stress coping bouts
Doyle, M. A., Brown, J. A., & Winder, D. G. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109377 · Cited by 5
Gakare, S. G., Shelkar, G. P., Gawande, D. Y., Pavuluri, R., Gandhi, P. J., & Dravid, S. M. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106784 · Cited by 5
Fritzemeier, R. G., Akins, N. S., Arcoria, P. J., Paladugu, S., Ullman, E. Z., Allen, J. P., Sheikh, R., Nocilla, K. A., McDaniels, E. D., Coleman, E. M., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02912 · Cited by 5
Self-citationExtending the Small Molecule Similarity Principle to All Levels of BiologyPreprint
Duran‐Frigola, M., Pauls, E., Guitart-Pla, O., Bertoni, M., Orozco-Ruiz, M., Alcalde, V., Diaz, V. M., Berenguer, A., Amat, D., Juan-Blanco, T., et al. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3380254 · Cited by 6
Gul, M. T., Khattak, M. N. K., Qaisar, R., Jayakumar, M. N., Samsudin, A. B. R., & Khan, A. A. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04702-1 · Cited by 5
The Sustained Antidepressant Effects of Ketamine Are Independent of the Lateral Habenula
Zhou, X., Zhang, C., Miao, J., Chen, Z., Dong, H., & Liu, C. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2521-20.2021 · Cited by 4
RetractedDoyle, M. A., Salimando, G. J., Altemus, M. E., Badt, J. K., Bedenbaugh, M. N., Vardy, A. S., Adank, D. N., Park, A. S., & Winder, D. G. (2024) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15432 · Cited by 3
Ringlet, S., Motta, Z., Vandries, L. M., Seutin, V., Jehasse, K., Caldinelli, L., Pollegioni, L., & Engel, D. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102773 · Cited by 3
Manning, C., Fritz, M., & Kauer, J. A. (2022) · eNeuro · doi:10.1523/eneuro.0324-22.2022 · Cited by 3
Selective Cell-Surface Expression of Triheteromeric NMDA Receptors
Yi, F., Traynelis, S. F., & Hansen, K. B. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3830-9_5 · Cited by 3
Self-citationA Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Pino, J. A., Awadallah, N., Norris, A. M., & Torres, G. E. (2021) · Journal of Visualized Experiments · doi:10.3791/62127 · Cited by 3
Camp, C. R., Vlachos, A., Klöckner, C., Krey, I., Banke, T. G., Shariatzadeh, N., Ruggiero, S. M., Galer, P. D., Park, K., Caccavano, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.29.474447 · Cited by 3
Self-citationPérez‐Sisqués, L., Bhatt, S., Caruso, A., Ahmed, M. U., Gileadi, T. E., Spring, S., Hendy, E., Taylor‐Papadimitriou, J., Cash, D., Clifton, N. E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.28.596232 · Cited by 3
Tang, Q., Zou, X., Ojiro, R., Ozawa, S., Koyanagi, M., Maronpot, R. R., Yoshida, T., & Shibutani, M. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105990 · Cited by 2
Inoue, S., Ikegaya, Y., Matsumoto, N., & Kashima, T. (2025) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2025.12.002 · Cited by 2
MORRIS, B. J. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111628 · Cited by 2
Kutluk, G., & Randa, N. C. (2021) · Acta Medica Alanya · doi:10.30565/medalanya.891938 · Cited by 2
Enhancement of hippocampal interneuron excitability by NMDA receptor positive allosteric modulation
Xing, H., Banke, T. G., Zhang, L., Yu, K., Camp, C. R., Fritzemeier, R. G., Akins, N. S., Paladugu, S., Arcoria, P. J., Brady, B. R., et al. (2025) · The Journal of Physiology · doi:10.1113/jp289774 · Cited by 1
Self-citationPérez‐Sisqués, L., Bhatt, S. R., Caruso, A., Robb, J. L., Donovan, A. P. A., Bamford, R. A., Torres-Cano, A., Spring, S., Hendy, E., Gileadi, T. E., et al. (2026) · Science Advances · doi:10.1126/sciadv.adq6577 · Cited by 1
Shedd, A., Jonak, C., Chan, L., Assad, S. A., Dravid, S., Gibson, J. R., Binder, D., & Huber, K. M. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.09.007 · Cited by 1
21st century excitatory amino acid research: A Q & A with Jeff Watkins and Dick Evans
Watkins, J. C., Evans, R. H., Bayés, À., Booker, S. A., Gibb, A. J., Mabb, A. M., Mayer, M. L., Mellor, J. R., Molnár, E., Niu, L., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108743 · Cited by 2
Berthoux, C., Rodenas-Ruano, A., Bist, L., Nasrallah, K., Castillo, M., Shelkar, G. P., Dravid, S. M., Swanger, S. A., & Castillo, P. E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.06.710109 · Cited by 1
Metadata
- Authors
- Perszyk, R. E., DiRaddo, J. O., Strong, K. L., Low, C.-M., Ogden, K. K., Khatri, A., Vargish, G. A., Pelkey, K. A., Tricoire, L., Liotta, D. C., Smith, Y., McBain, C. J., & Traynelis, S. F.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2016-12
- Volume
- 90
- Issue
- 6
- Pages
- 689-702
- ISSN
- 0026-895X (ISSN-L)
- PMC
- PMC5118640
- OpenAlex
- W2548997185
- Cited by
- 116
- References
- 59
- Citations by year
- 2026: 12 · 2025: 14 · 2024: 9 · 2023: 11 · 2022: 11 · 2021: 13 · 2020: 15 · 2019: 13 · 2018: 9 · 2017: 8 · 2016: 1
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Pharmacology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- University of Florida
- National Institutes of Health (P51OD011132)
- National Institute of General Medical Sciences (T32GM008602)
- National Institute of Neurological Disorders and Stroke (R01NS065371, R01NS036654)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- GluN2D, NMDA receptor, hippocampal interneurons, synaptic transmission, positive allosteric modulation, miniature excitatory postsynaptic currents, spontaneous inhibitory postsynaptic currents, CA1, glutamatergic synapses
- MeSH terms
- Allosteric Regulation, Animals, Hippocampus, Interneurons, Isoquinolines, Mice, Inbred C57BL, Synaptic Transmission, RNA, Messenger, Stereoisomerism, Time Factors, Xenopus laevis, Ion Channel Gating, Receptors, N-Methyl-D-Aspartate, Excitatory Postsynaptic Potentials, Rats, CA1 Region, Hippocampal, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review